UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,470 | +334.6% | 16,379 | +221.0% | 0.00% | – |
| Q2 2023 | $52,806 | +3129.7% | 5,102 | +2782.5% | 0.00% | – |
| Q1 2023 | $1,635 | -85.6% | 177 | -86.2% | 0.00% | – |
| Q4 2022 | $11,362 | -99.9% | 1,281 | -3.8% | 0.00% | – |
| Q3 2022 | $11,074,000 | -82.2% | 1,331 | -82.4% | 0.00% | – |
| Q2 2022 | $62,080,000 | +319.5% | 7,580 | +346.1% | 0.00% | – |
| Q1 2022 | $14,798,000 | -65.4% | 1,699 | -62.2% | 0.00% | – |
| Q4 2021 | $42,728,000 | -28.6% | 4,493 | +26.2% | 0.00% | – |
| Q3 2021 | $59,862,000 | +406.5% | 3,559 | +359.8% | 0.00% | – |
| Q2 2021 | $11,819,000 | -86.3% | 774 | -82.6% | 0.00% | – |
| Q1 2021 | $86,472,000 | +26.9% | 4,439 | +17.4% | 0.00% | – |
| Q4 2020 | $68,152,000 | -23.0% | 3,782 | -17.6% | 0.00% | – |
| Q3 2020 | $88,503,000 | +217.6% | 4,588 | +330.0% | 0.00% | – |
| Q2 2020 | $27,870,000 | -74.4% | 1,067 | -82.5% | 0.00% | – |
| Q1 2020 | $108,788,000 | +30.8% | 6,098 | +144.6% | 0.00% | – |
| Q4 2019 | $83,191,000 | +3.9% | 2,493 | -25.8% | 0.00% | – |
| Q3 2019 | $80,045,000 | – | 3,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |